Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
22:11:32 EDT Tue 27 Oct 2026
Enter Symbol
or Name
USA
CA



Q:CYDY - CYTODYN INC - https://www.cytodyn.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CYDY - Qnot subscribed0.2177-0.021546-9.03,200.76946490.24  0.24  0.21320.397  0.182915:58:57Oct 2615 min RT 2¢

Recent Trades - Last 10 of 649
Time ETExPriceChangeVolume
15:58:57Q0.2177-0.0215463,500
15:58:56Q0.2177-0.0215463,200
15:58:56Q0.2177-0.021546431
15:58:56Q0.2177-0.02154610,000
15:58:56Q0.2177-0.0215462,500
15:58:56Q0.2177-0.02154626,202
15:58:51Q0.2177-0.021546300
15:58:39Q0.2177-0.0215462,500
15:54:40Q0.21718-0.0220662,000
15:53:44Q0.2177-0.0215461,000

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-10-26 08:30U:CYDYNews ReleaseCytoDyn Presents Updated Leronlimab Data in Metastatic Colorectal Cancer at ESMO Congress 2026
2026-10-19 16:50U:CYDYNews ReleaseCytoDyn Appoints Robert E. Hoffman as Chief Executive Officer
2026-10-15 08:30U:CYDYNews ReleaseCytoDyn to Host Investor Webcast
2026-10-08 08:30U:CYDYNews ReleaseCytoDyn to Present Updated Data from Phase 2 CLOVER Clinical Study at ESMO Congress 2026
2026-09-15 08:30U:CYDYNews ReleaseCytoDyn Inc. to Present at the Life Sciences Investor Forum on September 17th
2026-09-01 08:30U:CYDYNews ReleaseCytoDyn Closes $16.5 Million Financing to Fund Continued Development of Leronlimab
2026-06-11 08:30U:CYDYNews ReleaseCytoDyn Announces First Patient Dosed in Phase 2a Study in Collaboration with Weill Cornell Medicine Evaluating Leronlimab in Alzheimer's Disease
2026-06-04 08:00U:CYDYNews ReleaseNatera and CytoDyn Announce Strategic Collaboration to Advance ctDNA-Guided Development and Molecular Response Analysis in Metastatic Colorectal Cancer
2026-06-03 08:30U:CYDYNews ReleasePlatform Biotech Models Draw Investor Eyes as Drug-Delivery Markets Head Toward $410 Billion
2026-05-15 08:30U:CYDYNews ReleaseCytoDyn to Present at the LD Micro Invitational XVI
2026-05-11 08:30U:CYDYNews ReleaseCNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities
2026-04-27 08:30U:CYDYNews ReleaseCytoDyn Announces First Patient Dosed in Expanded Access Program for Leronlimab in Triple-Negative Breast Cancer
2026-04-23 08:30U:CYDYNews ReleaseCytoDyn to Host Investor Webcast
2026-04-22 08:30U:CYDYNews ReleaseCytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026
2026-04-21 16:10U:CYDYNews ReleaseCytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study
2026-04-20 08:30U:CYDYNews ReleaseCytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026
2026-04-14 08:30U:CYDYNews ReleaseCytoDyn to Present at the AACR Annual Meeting 2026
2026-03-24 08:30U:CYDYNews ReleaseCytoDyn Presents at AACR Special Conference in Cancer Research: Brain Cancer
2026-03-05 08:30U:CYDYNews ReleaseCytoDyn Closes $17.5 Million Financing to Fund Continued Development of Leronlimab
2026-02-20 08:30U:CYDYNews ReleaseCytoDyn Presents Novel CCR5 Inhibition Mechanisms and Long-Term Survival Signals for Leronlimab in Metastatic Breast Cancer at AACR Immuno-Oncology Conference